HI
EDIT icon

Harbour Investments’s Editas Medicine EDIT Stock Holding History

Harbour Investments’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$305 Sell
94
-27
-22% -$79 ﹤0.01% 4470
2026
Q1 		$300 Buy
+121
New +$256 ﹤0.01% 4361
2025
Q4 		– Sell
-19
Closed -$66 – 3904
2025
Q3 		$66 Hold
19
– – ﹤0.01% 3667
2025
Q2 		$42 Hold
19
– – ﹤0.01% 3554
2025
Q1 		$22 Hold
19
– – ﹤0.01% 3520
2024
Q4 		$24 Hold
19
– – ﹤0.01% 3457
2024
Q3 		$65 Hold
19
– – ﹤0.01% 3336
2024
Q2 		$89 Sell
19
-74
-80% -$417 ﹤0.01% 3215
2024
Q1 		$690 Hold
93
– – ﹤0.01% 2992
2023
Q4 		$942 Sell
93
-245
-72% -$2.15K ﹤0.01% 2838
2023
Q3 		$2.64K Sell
338
-72
-18% -$617 ﹤0.01% 2484
2023
Q2 		$3.37K Sell
410
-80
-16% -$697 ﹤0.01% 2399
2023
Q1 		$3.55K Buy
490
+2
+0.4% +$18 ﹤0.01% 2401
2022
Q4 		$4.33K Buy
488
+26
+6% +$285 ﹤0.01% 2264
2022
Q3 		$5K Hold
462
– – ﹤0.01% 2162
2022
Q2 		$5K Buy
+462
New +$6.19K ﹤0.01% 2162
2021
Q4 		$22K Sell
812
-640
-44% -$22K ﹤0.01% 1624
2021
Q3 		$60K Buy
1,452
+579
+66% +$31.7K ﹤0.01% 1660
2021
Q2 		$49K Buy
873
+397
+83% +$14.7K ﹤0.01% 1824
2021
Q1 		$20K Buy
+476
New +$27.1K ﹤0.01% 2206

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Harbour Investments's EDIT Position: Q2 2026 in Review

Harbour Investments reduced its Editas Medicine (EDIT) stake by 22% in Q2 2026, selling an estimated $79 and leaving 94 shares worth $305. The position accounts for ﹤0.01% of the portfolio, ranked #4470.

Harbour Investments first reported a position in EDIT in Q1 2021 and has held it in 20 quarters since. The position peaked at $60K in Q3 2021. 214 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Harbour Investments held 94 shares of Editas Medicine worth $305 as of Q2 2026.
  • Harbour Investments sold 27 Editas Medicine shares in Q2 2026, an estimated $79.
  • Editas Medicine made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #4470 holding.
  • Harbour Investments first reported a position in Editas Medicine in Q1 2021 and has held it in 20 quarters since.
  • Harbour Investments's Editas Medicine position peaked at $60K in Q3 2021.
  • 214 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.